Pause in Rally as Large Cap Biotechs Are Weak 

There is significant weakness today in many high fliers that is not apparent in the S&P, NASDAQ and Russell averages. The IBB hit a new high yesterday at the $162 level and is off  1% today. Large Cap leaders YTD are also weak today AMGN, BIIB, GILD and CELG. Here are some significant losers among the MO stocks:

Amazon (AMZN $260) down 1.2%

Infinity Pharma (INFI $48.21) down 3.75%

Netflix (NFLX $169) down 4%

Pharmacyclics (PCYC $76.72) down 3.76%

Rayno Life Science Movers

Off YTD Highs:  AMRI down 5% , CBST off 2.8%, CSII down 3.4%, EXAS down 2.8%

New highs YTD: ASTX up 12%, REGN up 1.5%

Expect weak seasonality and wait for a correction. Look for a biotechnology rally as we approach ASCO meeting in late May. Diagnostics and tools are also weak but not as much as mid -cap biopharmaceuticals.



%d bloggers like this: